The effects of live Neisseria meningitidis and tumour necrosis factor-α on neutrophil oxidative burst and β2-integrin expression

APMIS

Volumn 108, Issue 4, 2000, Pages 276-282

  Kragsbjerg, P ^b   Fogelqvist, M ^a   Fredlund, H ^a  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b Lindesberg Hospital   (Sweden)

Author keywords

CD14; Neisseria meningitidis; Oxidative burst; Tumour necrosis factor ; 2 integrin

Indexed keywords

CD14 ANTIGEN; INTEGRIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL MENINGITIS; CENTRAL NERVOUS SYSTEM INFECTION; CHEMOLUMINESCENCE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MENINGITIS; NEISSERIA MENINGITIDIS; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY BURST;

EID: 0034069839     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2000.d01-56.x     Document Type: Article

References (16)

1. 1. Peltola H. Meningococcal disease: still with us. Rev Infect Dis 1983;5:71-91.
2. 2. Estabrook MM, Christoffer NC, Griffiss JM, Baker CJ, Mandrell RE. Sialylation and human neutrophil killing of group C Neisseria meningitidis. J Infect Dis 1992;166:1079-88.
3. 3. Brar DW, Borden EC, Proctor RA. Recombinant interferon-γ preserves human granulocyte bactericidal and chemiluminescence activities. J Infect Dis 1993;168:128-34.
4. 4. Ferrante A. Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candica albicans and associated increases in oxygen radical production and lysosymal enzyme release. Infect Immun 1989;57:2115-22.
5. 5. Ferrante A, Martin AJ, Bates EJ, et al. Killing of Staphylococcus aureus by tumor necrosis factor-α-activated neutrophils. J Immunol 1993;151:4821-8.
6. 6. Tan AM, Ferrante A, Goh DHB, Roberton DM, Cripps AW. Activation of the neutrophil bactericidal activity for nontypeable Haemophilus influenzae by tumor necrosis factor and lymphotoxin. Pediatr Res 1995;37:155-9.
7. 7. Fredlund H, Olcen P, Danielsson D. A reference procedure to study chemiluminescence induced in polymorphonuclear leukocytes by Neisseria meningitidis. APMIS 1988;96:941-9.
8. 8. Fredlund H, Sellden H, Danielsson D, Olcen P. Early development in healthy children of serum opsonins against nonpathogenic Neisseria meningitidis. APMIS 1992;100:449-54.
9. 9. Fredlund H, Sjoholm AG, Selander B, Holmstrom E, Olcen P, Danielsson D. Serum bactericidal activity and induction of chemiluminescence of polymorphonuclear leukocytes: complement activation pathway requirements in defense against Neisseria meningitidis. Int Arch Allergy Immunol 1993;100:135-43.
10. 10. Ross GD, Vetvicka V. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin Exp Immunol 1993;92:181-4.
11. 11. Lynn WA, Raetz CRH, Qureshi N, Golenbock DT. Lipopolysaccharide-induced stimulation of CD11b/cd18 expression on neutrophils. J Immunol 1991;147:3072-9.
12. 12. Wright SD, Ramos RA, Hermanowski-Vosatka A, Rockwell P, Detmers PA. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med 1991;173:1281-6.
13. 13. Olcen P, Danielsson D, Kjellander J. The use of protein A-containing staphylococci sensitized with anti-meningococcal antibodies for grouping Neisseria meningitidis and demonstration of meningococcal antigen in cerebrospinal fluid. Acta Path Microbiol Scand 1975;83:387-96.
14. 14. Martin E, Bakhdi S. Flow cytometric assay for quantifying opsonophagocytosis and killing of Staphylococcus aureus by peripheral blood leukocytes. J Clin Microbiol 1992;30:2246-55.
15. 15. Perticarari S, Presani G, Banfi E. A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood. J Immunol Methods 1994;170:117-24.
16. 16. Kragsbjerg P, Söderquist B, Holmberg H, Vikerfors T, Danielsson D. Production of tumour necrosis factor-α and interleukin-6 in whole blood stimulated by live Gram-negative and Gram-positive bacteria. Clin Microbiol Infect 1998;4:129-34.